NEW YORK, July 16, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

U.S. Market for Orthopedic Biomaterials 2012

The 2011 figures in the orthopedic biomaterials market show great promise for future performance of the orthopedic biomaterials market. To date there has been a multitude of products introduced to the market, with some becoming spectacular successes. Future growth for this market will be a result of continued improvements in product technology to meet the needs of patients as well as changes in healthcare reform and reimbursement. This comprehensive report covers a number of disciplines, including spinal surgery, sports medicine, tissue donation, and biotechnology. In each segment of this report, current market conditions are thoroughly examined and the behavior of each sub-segment over the forecast period is critically analyzed and cross-verified.


The Orthopedic biomaterials market includes:


• bone graft substitutes,

• growth factors,

• machined allografts,

• hyaluronic acid viscosupplementation,

• resorbable fixation devices,

• tendon grafts,

• cartilage repair,

• platelet and bone marrow concentration,

• orthopedic stem cells and

• emerging technologies


This report provides a comprehensive a